The Trump administration has lifted previously imposed restrictions on OpenAI's GPT 5.6 model. This regulatory shift removes barriers that were limiting deployment capabilities and competitive positioning for one of healthcare's most adopted large language models. Healthcare organizations and vendors relying on GPT-integrated clinical documentation, diagnostic support, and administrative workflows will gain access to more capable model versions without prior authorization requirements. The move signals a broader deregulatory approach that could accelerate AI adoption across EHR systems and patient-facing applications, though it also increases liability considerations for healthcare providers deploying unrestricted models in clinical settings.